Treatment of aggressive systemic mastocytosis with daclizumab.
Quintás-Cardama
Alfonso
A
Amin
Hesham M
HM
Kantarjian
Hagop
H
Verstovsek
Srdan
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D000077561:Daclizumab; D004334:Drug Administration Schedule; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D034721:Mastocytosis, Systemic / Q000188:drug therapy*; D011379:Prognosis; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D000077561:Daclizumab